Terént A, Andersson B
Acta Med Scand. 1980;208(5):359-65. doi: 10.1111/j.0954-6820.1980.tb01213.x.
Long-term anticoagulant treatment was given to 25 patients with transient ischemic attacks (TIA) and 49 stroke patients with reversible ischemic neurological deficit or cerebral embolism. Another 16 TIA patients were observed without anticoagulant treatment. Life table analyses, comparing the observed with the expected frequency, revealed increased mortality in the TIA patients irrespective of whether or not they had received anticoagulants. The stroke patients treated with anticoagulants also had a higher mortality than expected. On the other hand, the incidence of subsequent stroke was not higher than expected in the TIA and stroke patients treated with anticoagulants, while it was significantly increased in the TIA patients not treated with anticoagulants. Thus, the risk of stroke, but not the risk of death, was normalized by the anticoagulant treatment. Unacceptably serious bleeding complications were seen in the group of stroke patients with anticoagulant treatment. Bleeding complications, in both TIA and stroke patients, seemed to be related to lengthy treatment, high blood pressure on admission or insufficient patient compliance.
对25例短暂性脑缺血发作(TIA)患者以及49例患有可逆性缺血性神经功能缺损或脑栓塞的中风患者进行了长期抗凝治疗。另外16例TIA患者未接受抗凝治疗而进行观察。通过生命表分析,将观察到的频率与预期频率进行比较,发现无论是否接受抗凝治疗,TIA患者的死亡率均有所增加。接受抗凝治疗的中风患者死亡率也高于预期。另一方面,接受抗凝治疗的TIA和中风患者随后发生中风的发生率并不高于预期,而未接受抗凝治疗的TIA患者中风发生率则显著增加。因此,抗凝治疗可使中风风险(而非死亡风险)恢复正常。在接受抗凝治疗的中风患者组中出现了令人难以接受的严重出血并发症。TIA和中风患者的出血并发症似乎都与治疗时间长、入院时高血压或患者依从性不足有关。